| mRNA |
barasertib |
CTRPv2 |
pan-cancer |
AAC |
0.22 |
2e-10 |
| mRNA |
Erlotinib |
CCLE |
pan-cancer |
AAC |
0.3 |
8e-09 |
| mRNA |
decitabine:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.18 |
1e-07 |
| mRNA |
AZ-3146 |
CTRPv2 |
pan-cancer |
AAC |
0.18 |
9e-07 |
| mRNA |
indisulam |
CTRPv2 |
pan-cancer |
AAC |
0.16 |
2e-06 |
| mRNA |
ABT-737 |
CTRPv2 |
pan-cancer |
AAC |
0.18 |
5e-06 |
| mRNA |
alisertib:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.17 |
8e-06 |
| mRNA |
WZ3105 |
GDSC1000 |
pan-cancer |
AAC |
0.14 |
8e-06 |
| mRNA |
austocystin d |
CTRPv2 |
pan-cancer |
AAC |
0.17 |
1e-05 |
| mRNA |
ABT-263 |
CTRPv2 |
pan-cancer |
AAC |
0.17 |
1e-05 |